Indian Daratumumab Exporters: Complete Supplier Ranking with Market Share — 36 Manufacturers (2026) — TransData Nexus

Q: Who is the largest daratumumab supplier from India?

VAMA LIFECARE PRIVATE LIMITED is the largest daratumumab exporter from India with a 20.1% market share and export value of $268.2K.

Q: How many daratumumab suppliers are there in India?

There are 36 active daratumumab exporters in India, collectively shipping $1.3M worth of daratumumab across 209 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top daratumumab suppliers from India?

The top 5 daratumumab suppliers from India — VAMA LIFECARE PRIVATE LIMITED, NIVIRA EXPORTS, M. CARE, DOSHI MEDICARE PRIVATE LIMITED, 3S PHARMACEUTICALS INDIA PRIVATE LIMITED — together control 59.0% of total daratumumab export value from India.

Suresh Sormare

Daratumumab

India Pharmaceutical Trade Intelligence

$1.3M36 Suppliers23 CountriesHS 30049099

ExportsIndia → BRAZIL45.9%India → CAYMAN ISLANDS9.4%

ImportsSWITZERLAND → India$344.4M BELGIUM → India$4.9M

#1 Supplier: VAMA LIFECARE #1 Buyer: AS PER

Daratumumab Suppliers from India (2026) — 36 Exporters, $1.3M Market | TransData Nexus | TransData Nexus

Who Exports Daratumumab from India — 36 Suppliers Behind a $1.3M Market

India's daratumumab export market is supplied by 36 active exporters who collectively shipped $1.3M across 209 shipments. VAMA LIFECARE PRIVATE LIMITED leads with a 20.1% market share, followed by NIVIRA EXPORTS and M. CARE. The top 5 suppliers together control 59.0% of total export value, reflecting a moderately competitive market structure.

Source: Indian Customs (DGFT)·Published March 2026·

India's Top Daratumumab Suppliers & Exporters — 36 manufacturers, $1.3M export market, top destinations and formulations — Daratumumab supplier data — 36 exporters · $1.3M market · 209 shipmentsTransData Nexus · Indian Customs Data

Top Daratumumab Exporters from India — Ranked by Export Value

VAMA LIFECARE PRIVATE LIMITED is the leading daratumumab exporter from India, holding a 20.1% share of the $1.3M market across 209 shipments from 36 exporters. The top 5 suppliers — VAMA LIFECARE PRIVATE LIMITED, NIVIRA EXPORTS, M. CARE, DOSHI MEDICARE PRIVATE LIMITED, 3S PHARMACEUTICALS INDIA PRIVATE LIMITED — collectively control 59.0% of total export value, indicating a moderately concentrated market. Individual shares are: VAMA LIFECARE PRIVATE LIMITED (20.1%), NIVIRA EXPORTS (19.1%), M. CARE (7.6%), DOSHI MEDICARE PRIVATE LIMITED (7.4%), 3S PHARMACEUTICALS INDIA PRIVATE LIMITED (4.9%).

Top Daratumumab Exporters from India

Ranked by export value · 36 active suppliers · Indian Customs (DGFT) data

Mar 2026

Top Daratumumab Exporters from India — Ranked by Export Value. 36 active suppliers with export value, shipments, countries and formulations data compiled from Indian Customs records by TransData Nexus.
#	Supplier & Formulations	Value	Ships.	Ctry.	Share
1	VAMA LIFECARE PRIVATE LIMITED

Supplier Certification & Compliance Matrix

FDA, WHO-GMP, and EU GMP status for top Daratumumab exporters

Certification and compliance status for top Daratumumab suppliers from India
Supplier	US FDA	WHO-GMP	EU GMP	ANDAs	Notes
VAMA LIFECARE PRIVATE LIMITED	Not Listed	Yes (as of March 202	No	Not verified	WHO-GMP certification confirmed as of March 2026.
NIVIRA EXPORTS	Not Listed	Yes (as of March 202	No	Not verified	WHO-GMP certification confirmed as of March 2026.
M. CARE	Not Listed	Yes (as of March 202	No	Not verified	WHO-GMP certification confirmed as of March 2026.
DOSHI MEDICARE PRIVATE LIMITED	Not Listed	Yes (as of March 202	No	Not verified	WHO-GMP certification confirmed as of March 2026.
3S PHARMACEUTICALS INDIA PRIVATE LIMITED	Not Listed	Yes (as of March 202	No	Not verified	WHO-GMP certification confirmed as of March 2026.
VEA IMPEX (I) PRIVATE LIMITED	Not Listed	Yes (as of March 202	No	Not verified	WHO-GMP certification confirmed as of March 2026.
HUMANIQE BIOPHARMACEUTICALS PRIVATE LIMITED	Not Listed	Yes (as of March 202	No	Not verified	WHO-GMP certification confirmed as of March 2026.
RMPL PHARMA LLP	Not Listed	Yes (as of March 202	No	Not verified	WHO-GMP certification confirmed as of March 2026.
G P INTERGLOBE	Not Listed	Yes (as of March 202	No	Not verified	WHO-GMP certification confirmed as of March 2026.
MILES INTERNATIONAL	Not Listed	Yes (as of March 202	No	Not verified	WHO-GMP certification confirmed as of March 2026.

TransData Nexus reviewed the regulatory standing of 10 leading Daratumumab exporters from India. 0 hold US FDA facility approvals, 10 maintain WHO-GMP certification, and 0 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.

Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.

TransData Nexus Research · Mar 2026

Manufacturing Hub Analysis — Vendor Proximity

India's pharmaceutical clusters relevant to Daratumumab sourcing

1Hyderabad — Bulk Drug Capital

Hyderabad, often referred to as the "Bulk Drug Capital of India," is renowned for its extensive production of active pharmaceutical ingredients (APIs). The city's pharmaceutical ecosystem is supported by a robust infrastructure, including research institutions and manufacturing facilities, making it a pivotal hub for API production. While Hyderabad's primary focus is on APIs, the presence of comprehensive supply chains and skilled labor also facilitates the production of complex biologics like Daratumumab.

2Ahmedabad-Vadodara — Formulations Hub

The Ahmedabad-Vadodara corridor in Gujarat is a prominent center for pharmaceutical formulations. This region hosts numerous companies specializing in the development and manufacturing of finished dosage forms. The availability of advanced manufacturing technologies and a skilled workforce makes this cluster well-suited for producing injectable biologics such as Daratumumab. Additionally, the presence of equipment manufacturers, like those producing ampoule filling and sealing machines, supports the region's capability in sterile injectable production.

3Mumbai-Thane-Raigad — Export Gateway

Common Questions — Daratumumab Suppliers from India

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

Q Which daratumumab supplier from India is the most reliable for bulk orders?

Based on shipment frequency and export consistency, VAMA LIFECARE PRIVATE LIMITED leads with 29 recorded shipments worth $268.2K. NIVIRA EXPORTS (33 shipments) and M. CARE (6 shipments) are also established high-volume exporters.

Q How many daratumumab manufacturers are there in India?

India has 36 active daratumumab exporters with a combined export market of $1.3M across 209 shipments to 23 countries. The top 5 suppliers hold 59.0% of total export value.

Q What certifications should I verify?

Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).

Q What is the typical price range for daratumumab from India?

Average FOB unit price: $1001.99 per unit, ranging from $0.81 to $6136.46. Average shipment value: $6.4K.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Daratumumab

Daratumumab

Who Exports Daratumumab from India — 36 Suppliers Behind a $1.3M Market

Top Daratumumab Exporters from India — Ranked by Export Value

Top Daratumumab Exporters from India

Related Analysis

Need Details?

Supplier Certification & Compliance Matrix

Manufacturing Hub Analysis — Vendor Proximity

1Hyderabad — Bulk Drug Capital

2Ahmedabad-Vadodara — Formulations Hub

3Mumbai-Thane-Raigad — Export Gateway

Common Questions — Daratumumab Suppliers from India

Q Which daratumumab supplier from India is the most reliable for bulk orders?

Q How many daratumumab manufacturers are there in India?

Q What certifications should I verify?

Q What is the typical price range for daratumumab from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

4Baddi-Nalagarh — Tax Incentive Zone

5Sourcing Recommendations

Analysis Methodology